Status:
COMPLETED
Intraoperative Tissue Identification by Analyzing Surgical Smoke
Lead Sponsor:
Tampere University Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
SurgiNose is a single-center, non-randomized feasibility study aiming to evaluate the feasibility of intraoperative tissue analysis using differential mobility of surgical smoke generated with electro...
Detailed Description
The increasing number of breast cancer survivors and their longevity has emphasized the importance of aesthetic and functional outcomes of cancer surgery and increased pressure for the surgical treatm...
Eligibility Criteria
Inclusion
- Histologically confirmed primary malignancy of the breast
Exclusion
- \-
Key Trial Info
Start Date :
October 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 26 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04881331
Start Date
October 9 2019
End Date
December 26 2019
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TAYS Hatanpää
Tampere, Pirkanmaa, Finland, 33900